CHINA PHARMA HOLDINGS, INC. Impairment of Intangible Assets, Finite-lived
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Impairment of Intangible Assets, Finite-lived of $14.18 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2018-04-02
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets, finite-lived for fiscal 2017 was $14.18M, a 257.99% increase from fiscal 2016.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets, finite-lived for fiscal 2016 was $3.96M, a 3689.93% increase from fiscal 2015.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets, finite-lived for fiscal 2015 was $104.54K.
- CHINA PHARMA HOLDINGS, INC. impairment of intangible assets, finite-lived for fiscal 2014 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|
| 2017-12-31 | $14.18M 10-K · filed 2018-04-02 | |
| 2016-12-31 | $3.96M 10-K · filed 2018-04-02 | |
| 2015-12-31 | $104.54K 10-K · filed 2017-03-31 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 | |
| 2013-12-31 | $0.00 10-K · filed 2014-03-20 | |
| 2012-12-31 | $593.10K 10-K · filed 2014-03-20 | $1.77M 10-K · filed 2013-03-14 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |